India coronavirus vaccine market
is anticipated to witness double-digit CAGR in the forecast period,
FY2023-FY2027. The growth in the market can be attributed to increased demand
for preventive drugs and other related products; thereby supporting the growth
of the India coronavirus vaccine market in the next five years. In the end of
year 2019, the outbreak of COVID-19 was observed first in Wuhan City, China.
The infection later spread rapidly in other Asian countries and by March 2020,
World Health Organization (WHO) declared it a global pandemic. The world
observed a complete lockdown that affected end user industries including healthcare.
Healthcare facilities struggled with the administration of patients and their
cure while the market for almost all other products and services were shutdown.
Death toll that the pandemic caused and the number of complications the virus
caused in other patients gave a warning toward the severity of the concerns,
driving the growth of India coronavirus vaccine market. Moreover, governmental
aid toward the vaccination, availability of the vaccines systematically to all
the age groups are driving the market growth.
India is currently in the
overdrive process of providing vaccination against COVID-19 through fast track
development process. Although, more research is being conducted in order to
confirm the cure of a particular virus and fight against coronavirus. Coronavirus
vaccines safely deliver immunogen that is antigen specific which triggers human
immune-response system Human immune-response system generates antibodies
against the antigen and the B-cells are later stored as T-cells thereby
creating a memory response for the viral pathogen. In case of any future
infection by COVID-19 virulent, the immune system of the body responses based
on the memory cell responses and fights off disease. Furthermore, research is being
conducted to provide cost-effective vaccine with higher efficiency that can
create most effective T-cells that will completely fight off the virus attack.
India coronavirus vaccine market
is segmented by infection type, vaccine type, product type, route of administration,
patient type, end user, regional distribution, and competitional landscape. Based on vaccine type, the
market is further fragmented into virus vaccine, viral vector vaccine, nucleic
acid vaccines, protein based vaccine, and others. Virus vaccines are the
vaccines that use only a part or subunit of virus, whereas viral vector vaccine
specifically contain the inactivated form of the only vector that mobilizes the
virus in the human body. Nucleic acid vaccines are of two types, RNA based, and
DNA based; to overcome COVID-19, nucleic acid vaccines are a new approach that
contains only the genetic information of the virulent entity and is introduced
in the body. Protein based vaccines are specific viral proteins that are
produced by the genetic material of virus thereby these vaccines would generate
antibodies that digest these proteins thus inactivating effects.
Some of the top players in
the India coronavirus vaccine market include Serum Institute of India Pvt. Ltd.,
Bharat Biotech International Ltd., Zydus Cadila Ltd., Pfizer India Ltd., Panacea
Biotec Ltd., Indian Immunologicals Ltd., Mynvax Pvt. Ltd., Biological E Ltd., Hetero
Biopharma Ltd., Dr Reddy’s Laboratories Ltd., among others. The companies are
involving themselves into research and development for the methods of better
quality, and various quality analysis tests to provide the better products.
Years considered
for this report:
Historical
Years: FY2017 – FY2020
Base Year: FY2021
Estimated Year:
FY2022
Forecast Period:
FY2023 – FY2027
Objective of the Study:
- To analyze the
historical growth of the market size of India coronavirus vaccine market
from FY2017 to FY2020.
- To estimate and forecast the market size of India
coronavirus vaccine market from FY2021 to FY2027 and growth rate until FY2027.
- To classify and forecast India coronavirus vaccine market based on infection type, vaccine type, product type, route
of administration, patient type, end user, regional
distribution, and competitional landscape.
- To identify dominant region or segment in the India
coronavirus vaccine market.
- To identify drivers and challenges for India coronavirus
vaccine market.
- To examine competitive developments such as
expansions, new product launches, mergers & acquisitions, etc., in
India coronavirus vaccine market.
- To identify
and analyze the profile of leading players operating in India coronavirus vaccine market.
- To identify key sustainable strategies adopted
by market players in India coronavirus vaccine market.
Click here to download the sample
TechSci Research performed both
primary as well as exhaustive secondary research for this study. Initially,
TechSci Research sourced a list of manufacturers, suppliers, and service
providers across the country. Subsequently, TechSci Research conducted primary
research surveys with the identified companies. While interviewing, the
respondents were also enquired about their competitors. Through this technique,
TechSci Research could include the manufactures which could not be identified
due to the limitations of secondary research. TechSci Research analyzed the manufactures,
distribution channels and presence of all major players across the country.
TechSci Research calculated the
market size of India coronavirus vaccine market using a bottom-up approach,
wherein data for various end-user segments was recorded and forecast for the
future years. TechSci Research sourced these values from the industry experts
and company representatives and externally validated through analysing
historical data of these product types and applications for getting an
appropriate, overall market size. Various secondary sources such as company
websites, news articles, press releases, company annual reports, investor
presentations and financial reports were also studied by TechSci Research.
Key Target Audience:
- Coronavirus vaccine manufacturers, end
users, and other stakeholders
- Distributers and suppliers of Coronavirus
vaccines and other stakeholders
- Organizations, forums, and alliances
related to coronavirus vaccines
- Market research and consulting firms
The study is useful in providing
answers to several critical questions that are important for the industry
stakeholders such as manufacturers, suppliers, end users, etc., besides
allowing them in strategizing investments and capitalizing on market
opportunities.
Report Scope:
In this report,
India coronavirus vaccine market has been segmented into following
categories, in addition to the industry trends which have also been detailed
below:
- India Coronavirus Vaccine Market, By Infection Type:
- SARS-CoV
- MERS-CoV
- SARS-CoV-2
- India Coronavirus
Vaccine Market, By Vaccine Type:
o
Virus vaccine
o
Viral vector vaccine
o
Nucleic acid vaccines
o
Protein based vaccine
o
Others
- India Coronavirus
Vaccine Market, By Product Type:
o
Monovalent Vaccine
o
Multivariant Vaccine
- India
Coronavirus Vaccine Market, By Route of Administration:
o
Oral
o
Intramuscular
o
Intranasal
- India
Coronavirus Vaccine Market, By Patient Type:
o
Pediatric
o
Adult
- India
Coronavirus Vaccine Market, By End User:
o
Hospitals
o
Clinics
o
Research Institutes
o
Others
- India Coronavirus
Vaccine Market, By Region:
Competitive
Landscape
Company Profiles: Detailed analysis of the major
companies present in India Coronavirus vaccine market.
Available
Customizations:
With the given market data, TechSci
Research offers customizations according to a company’s specific needs. The
following customization options are available for the report:
Company Information
- Detailed
analysis and profiling of additional market players (up to five).
India Coronavirus Vaccine Market
is an upcoming report to be released soon. If you wish an early delivery of
this report or want to confirm the date of release, please contact us at [email protected]